Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Neoadjuvant intra-arterial chemotherapy combined with radiotherapy and surgery in patients with advanced maxillary sinus cancer

  • Kim, Won Taek (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Nam, Jiho (Department of Radiation Oncology, Pusan National University Yangsan Hospital) ;
  • Ki, Yong Kan (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Lee, Ju Hye (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Kim, Dong Hyun (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Park, Dahl (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Cho, Kyu Sup (Department of Otolaryngology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Roh, Hwan Jung (Department of Otolaryngology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine) ;
  • Kim, Dong Won (Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine)
  • Received : 2013.04.02
  • Accepted : 2013.06.21
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The optimal treatment of advanced maxillary sinus cancer has been challenging for several decades. Intra-arterial chemotherapy (IAC) for head and neck cancer has been controversial. We have analyzed the long-term outcome of neoadjuvant IAC followed by radiation therapy (RT) and surgery. Materials and Methods: Twenty-seven patients with advanced maxillary sinus cancer were treated between 1989 and 2002. Five-fluorouracil (5-FU, $500mg/m^2$) was infused intra-arterially, and followed by RT (total 50.4 Gy/28 fractions). A planned surgery was performed 3 to 4 weeks after completion of IAC and RT. Results: At a median follow-up of 77 months (range, 12 to 169 months), the 5-year rates of overall survival in all patients were 63%. The 5-year rates of overall survival of stage T3/T4 patients were 70.0% and 58.8%, respectively. Seven of fourteen patients with disease recurrence had a local recurrence alone. The 5-year actuarial local control rates in patients with stage T3/T4, and in all patients were 20.0%, 32.3%, and 27.4%, respectively. Overall response rate after the completion of IAC and RT was 70.3%. During the follow-up, seven patients (25.9%) showed mild to moderate late complications. The tumor extent (i.e., the involvement of either orbit and/or base of skull) appeared to be related with local recurrence. Conclusion: Neoadjuvant IAC with 5-FU followed by RT and surgery may be effective to improve local tumor control in the patients with advanced maxillary sinus cancer. However, local failure was still the major cause of death. Further investigations are required to determine the optimal treatment schedule, radiotherapy techniques and chemotherapy regimens.

Keywords

References

  1. Roush GC. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg 1979;2:3-11. https://doi.org/10.1002/hed.2890020103
  2. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92:3012-29. https://doi.org/10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E
  3. Ganly I, Patel SG, Singh B, et al. Craniofacial resection for malignant paranasal sinus tumors: report of an International Collaborative Study. Head Neck 2005;27:575-84. https://doi.org/10.1002/hed.20165
  4. Blanco AI, Chao KS, Ozyigit G, et al. Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:51-8. https://doi.org/10.1016/j.ijrobp.2003.09.101
  5. Isobe K, Uno T, Hanazawa T, et al. Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus. Jpn J Clin Oncol 2005;35:633-8. https://doi.org/10.1093/jjco/hyi178
  6. Yoshimura R, Shibuya H, Ogura I, et al. Trimodal combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2002;53:656-63. https://doi.org/10.1016/S0360-3016(02)02771-2
  7. Samant S, Robbins KT, Vang M, Wan J, Robertson J. Intraarterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg 2004;130:948-55. https://doi.org/10.1001/archotol.130.8.948
  8. Shiga K, Yokoyama J, Hashimoto S, et al. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg 2007;136:1003-9. https://doi.org/10.1016/j.otohns.2006.12.018
  9. Resto VA, Chan AW, Deschler DG, Lin DT. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008;30:222-9. https://doi.org/10.1002/hed.20681
  10. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting: the MSKCC experience. Int J Radiat Oncol Biol Phys 2007;67:691-702. https://doi.org/10.1016/j.ijrobp.2006.09.023
  11. Chen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007;69:141-7. https://doi.org/10.1016/j.ijrobp.2007.02.031

Cited by

  1. Fluorouracil : Skin erythema: case report vol.1532, pp.1, 2013, https://doi.org/10.1007/s40278-014-5913-0
  2. Outcome of Definitive and Postoperative Radiotherapy in Patients with Sinonasal Squamous Cell Carcinomas vol.102, pp.4, 2013, https://doi.org/10.5301/tj.5000431
  3. Therapeutic efficacy of regional and systemic chemotherapy in advanced maxillary sinus cancer vol.41, pp.8, 2013, https://doi.org/10.1002/hed.25752